Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Neuro-Oncology|July 12, 2007
Antiangiogenic and anti-invasive effects of sunitinib on experimental human glioblastomaSophie de Boüard, Paulette Herlin, James G Christensen, et al.
Proteomics|August 31, 2006
Comparative proteomic analysis of cisplatin sensitive IGROV1 ovarian carcinoma cell line and its resistant counterpart IGROV1-R10Karen Le Moguen, Hubert Lincet, Edwige Deslandes, et al.
Molecular Imaging and Biology|June 11, 2008
Usefulness of automatic quantification of immunochemical staining on whole tumor sections for correlation with oncological small animal PET studies: an example with cell proliferation, glucose transporter 1 and FDGNicolas Aide, Alexandre Labiche, Paulette Herlin, et al.
Molecular Cancer Therapeutics|November 6, 2009
Mcl-1 is an important determinant of the apoptotic response to the BH3-mimetic molecule HA14-1 in cisplatin-resistant ovarian carcinoma cellsKarin Simonin, Emilie Brotin, Sandrine Dufort, et al.
Molecular Cancer Therapeutics|December 17, 2016
The mTORC1/2 Inhibitor AZD8055 Strengthens the Efficiency of the MEK Inhibitor Trametinib to Reduce the Mcl-1/[Bim and Puma] ratio and to Sensitize Ovarian Carcinoma Cells to ABT-737Cécile Pétigny-Lechartier, Charlène Duboc, Abdelghani Jebahi, et al.
Journal of Ovarian Research|June 6, 2013
Sensitization of ovarian carcinoma cells to Bcl-xL-targeting strategies through indirect modulation of Mcl-1 activity by MR22388, a molecule of the tripentone familyJulie Tomasina, Aurélie Malzert-Freon, Florence Giffard, et al.
Proteomics|November 13, 2007
A proteomic kinetic analysis of IGROV1 ovarian carcinoma cell line response to cisplatin treatmentKaren Le Moguen, Hubert Lincet, Paulo Marcelo, et al.
Histology and Histopathology|February 19, 2009
Prognostic significance of tumour vascularisation on survival of patients with advanced ovarian carcinomaAlexandre Labiche, Nicolas Elie, Paulette Herlin, et al.
The Journal of Experimental Medicine|October 18, 2006
Follicular lymphoma-like B cells in healthy individuals: a novel intermediate step in early lymphomagenesisSandrine Roulland, Jean-Marc Navarro, Pierre Grenot, et al.
Carcinogenesis|February 10, 2010
Downregulation of Bcl-xL and Mcl-1 is sufficient to induce cell death in mesothelioma cells highly refractory to conventional chemotherapyEmilie Varin, Christophe Denoyelle, Emilie Brotin, et al.
Pageof 5